UV/H2O2degradation of the antidepressants venlafaxine and O-desmethylvenlafaxine: Elucidation of their transformation pathway and environmental fate

Journal of Hazardous Materials

Volumn 311, Issue , 2016, Pages 70-80

  García Galán, Jesús ^a   Anfruns, Alba ^a   Gonzalez Olmos, Rafael ^a,b   Rodríguez Mozaz, Sara ^c   Comas, Joaquim ^a,c  

^a UNIVERSITY OF GIRONA   (Spain)

^b Institut Químic de Sarrià Universitat Ramon Llull   (Spain)

^c CATALAN INSTITUTE FOR WATER RESEARCH ICRA   (Spain)

Author keywords

Ecotoxicity; Metabolite; Transformation products; UV H2O2 oxidation; Venlafaxine

Indexed keywords

BACTERIA; DRUG PRODUCTS; HIGH PRESSURE LIQUID CHROMATOGRAPHY; LINEAR TRANSFORMATIONS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES;

BIOLUMINESCENCE INHIBITIONS; DEGRADATION PATHWAYS; ECOTOXICITY; HIGH RESOLUTION MASS SPECTROMETRY; TRANSFORMATION PATHWAYS; TRANSFORMATION PRODUCTS; ULTRA HIGH PRESSURE LIQUID CHROMATOGRAPHY (UHPLC); VENLAFAXINE;

MATHEMATICAL TRANSFORMATIONS;

DESVENLAFAXINE; HYDROGEN PEROXIDE; VENLAFAXINE; ANTIDEPRESSANT AGENT;

BACTERIUM; DEGRADATION; DRUG; ECOTOXICOLOGY; ENVIRONMENTAL FATE; HYDROGEN PEROXIDE; INHIBITION; METABOLITE; OXIDATION; REACTION RATE; TRANSFORMATION; ULTRAVIOLET RADIATION;

ALIIVIBRIO FISCHERI; ARTICLE; BIOLUMINESCENCE; BIOMINERALIZATION; CHEMICAL STRUCTURE; DRUG TRANSFORMATION; ECOTOXICITY; ENVIRONMENTAL IMPACT; HYDROXYLATION; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; OXIDATION; PHOTODEGRADATION; PHOTOLYSIS; QUANTUM YIELD; RATE CONSTANT; REACTION TIME; STEADY STATE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET RADIATION; CHEMISTRY; DRUG EFFECTS; METABOLISM; RADIATION RESPONSE;

VIBRIO FISCHERI;

ALIIVIBRIO FISCHERI; ANTIDEPRESSIVE AGENTS; DESVENLAFAXINE SUCCINATE; HYDROGEN PEROXIDE; PHOTOLYSIS; ULTRAVIOLET RAYS; VENLAFAXINE HYDROCHLORIDE;

EID: 84959316203     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2016.02.070     Document Type: Article

References (35)

1. Fatta-Kassinos D., Meric S., Nikolaou A. Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research. Anal. Bioanal. Chem. 2011, 399:251-275.
2. Topp E., Monteiro S.C., Beck A., Coelho B.B., Boxall A.B.A., Duenk P.W., Kleywegt S., Lapen D.R., Payne M., Sabourin L., Li H., Metcalfe C.D. Runoff of pharmaceuticals and personal care products following application of biosolids to an agricultural field. Sci. Total Environ. 2008, 396:52-59.
3. Kümmerer K. Pharmaceuticals in the Environment-Soruces, Fate, Effects and Risks 2008, Springer, Berlin-Heidelberg-New York.
4. European Union, Council Directive 91/271/EEC concerning urban waste-water treatment (1991).
5. Göbel A., McArdell C.S., Joss A., Siegrist H., Giger W. Fate of sulfonamides macrolides, and trimethoprim in different wastewater treatment technologies. Sci. Total Environ. 2007, 372:361-371.
6. Gros M., Petrovic M., Ginebreda A., Barceló D. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ. Int. 2010, 36:15-26.
7. Pedrouzo M., Borrull F., Pocurull E., Marcé R.M. Presence of pharmaceuticals and hormones in waters from sewage treatment plants. Water Air Soil Pollut. 2011, 217:267-281.
8. Benitez F.J., Acero J.L., Real F.J., Roldan G., Casas F. Comparison of different chemical oxidation treatments for the removal of selected pharmaceuticals in water matrices. Chem. Eng. J. 2011, 168:1149-1156.
9. Oller I., Malato S., Sánchez-Pérez J.A. Combination of advanced oxidation processes and biological treatments for wastewater decontamination-a review. Sci. Total Environ. 2011, 409:4141-4166.
10. Huber M.M., Canonica S., Park G.Y., Von Gunten U. Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ. Sci. Technol. 2003, 37:1016-1024.
11. Klavarioti M., Mantzavinos D., Kassinos D. Removal of residual pharmaceuticals from aqueous systems by advanced oxidation processes. Environ. Int. 2009, 35:402-417.
12. 2 treatment for the oxidation of pharmaceuticals in wastewater. Water Res. 2010, 44:1440-1448.
13. Köhler C., Venditti S., Igos E., Klepiszewski K., Benetto E., Cornelissen A. Elimination of pharmaceutical residues in biologically pre-treated hospital wastewater using advanced UV irradiation technology: a comparative assessment. J. Hazard. Mater. 2012, 239-240:70-77.
14. 2. Water Res. 2013, 47:5876-5888.
15. 2/UV treatment of clofibric acid in water: a kinetic investigation. J. Hazard. Mater. 2003, 103:233-246.
16. 2/UV system. Water Res. 2003, 37:993-1004.
17. Fatta-Kassinos D., Vasquez M.I., Kümmerer K. Transformation products of pharmaceuticals in surface waters and wastewater formed during photolysis and advanced oxidation processes-degradation, elucidation of byproducts and assessment of their biological potency. Chemosphere 2011, 85:693-709.
18. de Jongh P.J.F., de Voogt P., ter Laak T.L. Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface waters and drinking water. Sci. Total Environ. 2012, 427-428:70-77.
19. Donner E., Kosjek T., Qualmann S., Kusk K.O., Heath E., Revitt D.M., Ledin A., Andersen H.R. Ecotoxicity of carbamazepine and its UV photolysis transformation products. Sci. Total Environ. 2013, 443:870-876.
20. Cleuvers M. Mixture toxicity of the anti-inflammatory drugs diclofenac ibuprofen, naproxen, and acetylsalicylic acid. Ecotoxicol. Environ. Saf. 2004, 59:309-315.
21. Beel R., Lütke Eversloh C., Ternes T.A. Biotransformation of the UV-filter sulisobenzone: challenges for the identification of transformation products. Environ. Sci. Technol. 2013, 47:6819-6828.
22. Wick A., Wagner M., Ternes T.A. Elucidation of the transformation pathway of the opium alkaloid codeine in biological wastewater treatment. Environ. Sci. Technol. 2011, 45:3374-3385.
23. European Union, Commission Decision 2002/657/EC implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results, Off. J. Eur. Union (2002), 10-32.
24. García-Galán M.J., Díaz-Cruz M.S., Barceló D. Kinetic studies and characterization of photolytic products of sulfamethazine, sulfapyridine and their acetylated metabolites in water under simulated solar irradiation. Water Res. 2012, 46:711-722.
25. Gómez M.J., Gómez-Ramos M.M., Malato O., Mezcua M., Férnandez-Alba A.R. Rapid automated screening, identification and quantification of organic micro-contaminants and their main transformation products in wastewater and river waters using liquid chromatography-quadrupole-time-of-flight mass spectrometry with an accurate-mass database. J. Chromatogr. A 2010, 1217:7038-7054.
26. (29.10.15). http://www.aemps.gob.es/cima/especialidad.do%3Fmetodo=verPresentaciones%26codigo=75561.
27. Schultz M.M., Furlong E.T. Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS. Anal. Chem. 2008, 80:1756-1762.
28. Schultz M.M., Furlong E.T., Kolpin D.W., Werner S.L., Schoenfuss H.L., Barber L.B., Blazer V.S., Norris D.O., Vajda A.M. Antidepressant pharmaceuticals in two U.S. effluent-impacted streams: occurrence and fate in water and sediment and selective uptake in fish neural tissue. Environ. Sci. Technol. 2010, 44:1918-1925.
29. Collado N., Rodriguez-Mozaz S., Gros M., Rubirola A., Barceló D., Comas J., Rodriguez-Roda I., Buttiglieri G. Pharmaceuticals occurrence in a WWTP with significant industrial contribution and its input into the river system. Environ. Pollut. 2014, 185:202-212.
30. Gros M., Rodriguez-Mozaz S., Barcelo D. Fast and comprehensive multi-residue analysis of a broad range of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry. J. Chromatogr. A 2012, 104-121.
31. Valcárcel Y., González Alonso S., Rodríguez-Gil J.L., Gil A., Catalá M. Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid Region (Spain) and potential ecotoxicological risk. Chemosphere 2011, 84:1336-1348.
32. Lajeunesse A., Gagnon C., Sauvé S. Determination of basic antidepressants and their N-desmethyl metabolites in raw sewage and wastewater using solid-phase extraction and liquid chromatography-tandem mass spectrometry. Anal. Chem. 2008, 80:5325-5333.
33. Godayol A., Gonzalez-Olmos R., Sanchez J.M., Anticó E. Assessment of the effect of UV and chlorination in the transformation of fragrances in aqueous samples. Chemosphere 2015, 125:25-32.
34. Santoke H., Song W., Cooper W.J., Peake B.M. Advanced oxidation treatment and photochemical fate of selected antidepressant pharmaceuticals in solutions of Suwannee River humic acid. J. Hazard. Mater. 2012, 217-218:382-390.
35. Lajeunesse A., Blais M., Barbeau B., Sauve S., Gagnon C. Ozone oxidation of antidepressants in wastewater-treatment evaluation and characterization of new by-products by LC-Q To FMS. Chem. Cent. J. 2012, 7:15.